Ingredient guide
What is berberine?
What berberine is and what safety guidance says
Berberine is a substance found in plants including goldenseal, barberry and Oregon grape. Human trials commonly report gastrointestinal side effects. NCCIH cautions about medication interactions, including cyclosporine, and possible harm during pregnancy or breastfeeding; it considers berberine likely unsafe for infants. This describes plant occurrence, not evidence that a supplement improves a health outcome. These findings concern gastrointestinal adverse effects reported in the umbrella review; they do not establish safety during pregnancy or breastfeeding, with other medications, at a particular dose, or with long-term use. This is a medication-interaction caution, not advice to stop, replace or change a prescribed medicine. This caution concerns infants, pregnancy and breastfeeding; the cited guidance links berberine exposure to harmful bilirubin buildup in infants.[1], [2]
Scope and limitations
The umbrella review concluded that the methodological quality of the evidence needs improvement. The liver-enzyme finding is a pooled group average and does not establish individual outcomes. An evidence-quality caveat from the umbrella review itself, not a claim about any specific outcome or dose. This is a pooled group-average liver-enzyme result from 12 randomized trials. It does not establish individual safety or effects outside the studied populations and protocols.[2], [3]
Sources behind the starting answer
Read the full evidence summary →
Sources for this section
- Berberine and Weight Loss: What You Need To Know. NIH National Center for Complementary and Integrative Health. Retrieved 2026-09-09. Government health fact sheet View source →
- Berberine and health outcomes: An umbrella review.. Phytotherapy research : PTR. 2023. Systematic review View source →
- The effect of berberine supplementation on obesity parameters, inflammation and liver function enzymes: A systematic review and meta-analysis of randomized controlled trials.. Clinical nutrition ESPEN. 2020. Systematic review and meta-analysis View source →
What blood-glucose trials studied
In adults with type 2 diabetes, pooled randomized-trial evidence suggests berberine may be associated with lower fasting blood glucose, although the underlying trials are limited. Evidence is specific to adults with type 2 diabetes (not the general or healthy public). The pooled trials show high statistical heterogeneity and are mostly of low-to-moderate quality. The review reports publication-bias concerns. This is general information, not medical advice or a treatment recommendation. Trials used differing regimens; these results do not establish a dose or duration recommendation.[1]
Scope and limitations
The pooled trials show high statistical heterogeneity and are mostly of low-to-moderate quality. The review reports publication-bias concerns. These findings concern adults with type 2 diabetes and do not establish a benefit for people without that condition.[1]
This is general information, not medical advice or a treatment recommendation, and berberine is not a substitute for prescribed therapy. Reflects the heterogeneity, quality, and publication-bias concerns noted in the meta-analysis; berberine is not a substitute for prescribed therapy.[1]
Read the full evidence summary →
Sources for this section
- Effects of berberine on blood glucose in patients with type 2 diabetes mellitus: a systematic literature review and a meta-analysis. Endocrine Journal. 2019. Systematic review and meta-analysis View source →
What weight studies can establish
Pooled randomized controlled trials suggest berberine, typically taken at about 500 mg two to three times daily, is associated with modest average reductions in body weight, BMI and waist circumference. The effects are small and not uniform across analyses, so the popular 'nature's Ozempic' framing is marketing rather than evidence of a GLP-1-drug-equivalent result. Pooled across 12 randomized controlled trials at oral doses commonly around 500 mg taken two to three times daily; the average reduction was small (about 2 kg) and results across analyses are not uniform. At oral doses commonly around 500 mg two to three times daily; the pooled reductions were small (roughly 0.3 to 0.5 kg/m2) and represent group averages, not an Ozempic-like or GLP-1-equivalent effect. Based on pooled randomized controlled trials whose individual results the authors describe as inconsistent; effects vary by outcome measured.[1], [2]
Scope and limitations
These findings come from meta-analyses of a modest number of mostly small randomized trials, many in people with metabolic disorders rather than otherwise-healthy adults seeking weight loss. Pooled body-weight results conflict between analyses, average effects are small, and none of this supports the idea that berberine matches the weight-loss magnitude of prescription GLP-1 medications.[1], [2]
Read the full evidence summary →
Sources for this section
- The effect of berberine supplementation on obesity parameters, inflammation and liver function enzymes: A systematic review and meta-analysis of randomized controlled trials.. Clinical nutrition ESPEN. 2020. Systematic review and meta-analysis View source →
- The effect of berberine supplementation on obesity indices: A dose- response meta-analysis and systematic review of randomized controlled trials.. Complementary therapies in clinical practice. 2020. Systematic review and meta-analysis View source →
This page is educational, not individualized medical advice. A study protocol is not a personal dosing instruction. Study descriptions do not replace professional care. Ingredient research does not establish that a particular ranked product works.
Explore the berberine guide by question
The structured guide connects this foundational page to the product comparison and focused research summaries.
Open the full berberine guide →
Berberine and Blood Sugar
The main metabolic use case: fasting glucose and type 2 diabetes research context.
Read answer →Berberine Dosage
How dosing is typically discussed in berberine research and product labels.
Read answer →Berberine Side Effects
Safety, tolerability, and interaction context that should sit close to buying-intent paths.
Read answer →Berberine and Cholesterol
Evidence context for cholesterol and lipid-related berberine claims.
Read answer →Berberine and Weight Loss
What weight-loss research says, and why expectations need to stay modest.
Read answer →Berberine and PCOS
PCOS-specific research context and how it relates to insulin-resistance claims.
Read answer →Product comparison
An evidence-informed comparison of leading berberine supplements, evaluated on form, labeled dose, transparency, and testing.